In an interview with PharmaShots, Douglas E. Williams, Ph.D., President and Chief Executive Officer of Codiak BioSciences shares insights on the potential of engineered exosomes and the data presented at […]readmore
Tags : Potential
Shots: Eli Lilly reported that first patients have been dosed in a P-I study of LY-CoV555, the first Ab emerge from the collaboration b/w Lilly & AbCellera to create Ab […]readmore
Shots: The P-II study involves assessing of Bavencio in 15 women (median age 34yrs.) with GTT that are resistant to mono-CT. All patients had progressed on treatment with MTX; one […]readmore
Shots: Merck allied with ISB and a consortium of companies to investigate the molecular mechanisms of SARS-CoV-2 Infection and to identify new targets for potential COVID-19 therapeutics and vaccines The […]readmore
Shots: Fresenius Kabi voluntarily recalls two lots of Fluorouracil Injection with a lot number 6120341 and 6120420 to the consumer level due to the presence of glass particulate, distributed between […]readmore